← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2015Last known activity
Mar 15, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05908643CollaboratorPhase 1/Phase 2Mar 15, 2023
- NCT04426123CollaboratorPhase 2Jul 1, 2020
- NCT03620266CollaboratorN/ANov 1, 2018
- NCT02477280Overall official - principal investigatorPhase 4Nov 1, 2015
- NCT02477280Lead sponsorPhase 4Nov 1, 2015
- NCT02477280Reponsible party - principal investigatorPhase 4Nov 1, 2015
- NCT02473185Lead sponsorPhase 4Sep 1, 2015
- NCT02473185Reponsible party - principal investigatorPhase 4Sep 1, 2015
- NCT02473185Overall official - principal investigatorPhase 4Sep 1, 2015
Details
- Last known activity
- Mar 15, 2023